首页 > 最新文献

Brain, Behavior, and Immunity最新文献

英文 中文
Temporally-regulated genetic access to IL-1β-expressing cellular networks in homeostasis and following peripheral or central immune stimuli 在稳态和外周或中枢免疫刺激后,il -1β表达细胞网络的临时调控遗传通路。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106177
Daniel P. Nemeth , Xiaoyu Liu , Loretta Chen , Margaret R. Hawkins , Haroon S. Ali , Madison G. Lapid , Vesal Farsian , Ashley Kim , Julianna Saez , Gabriella Maxey , Numana Luqman , Samantha McGovern , Matt Schrier , Chris Vargas , Josh St. Juste-Ellis , Jasmine Yip , Joris Romain , Adam D. Bachstetter , Ning Quan

Background

The proinflammatory cytokine Interleukin-1 beta (IL-1β) regulates nearly all aspects of immune function. In the brain, IL-1β is implicated in neural and immune functions under both basal and inflammatory conditions. Under basal conditions, IL-1β is known to alter sleep, memory, and affect. Under inflammatory conditions, IL-1β can induce sickness behaviors, HPA activation, and exacerbate neurological and psychological disorders. Sensitive detection and specific manipulation of IL-1β-expressing cells in the brain is currently not achievable; therefore, we generated the first mouse line to allow both robust visualization and genetic manipulation of the IL-1β-expressing cells.

Methods

The IL-1β-TRAP mouse was generated through Crispr9-mediated recombination. IRES-CreERT2 was inserted following exon 7 after the stop codon of the Il1b gene which yielded an IL-1β-IRES-Cre-ERT2 mouse (IL-1β-TRAP). To visualize IL-1β-expressing cells, IL-1β-IRES-Cre-ERT2 line was crossed with ROSA26-lox-stop-lox-tdTomato mouse to generate the IL-1β-IRES-Cre-ERT2:ROSA26-lox-stop-lox-tdTomato (IL-1β-TRAP-reporter). The IL-1β-TRAP-reporter mice were given intraperitoneal (i.p.) Tamoxifen before peripheral LPS or central IL-1β administration. PBS was used as control. The IL-1β-TRAP-reporter mice were also exposed to repetitive closed head injury (CHI) or i.p. kainic acid. tdTomato was allowed to express for 7d and distribution of IL-1β-expressing cells were observed via immunohistochemistry and/or lightsheet microscopy.

Results

Under basal conditions, IL-1β was found primarily to be expressed in MHCII+ and CD206+ meningeal and ventricular macrophages with sparse IL-1β-expressing microglia and neurons in brain parenchyma. Following i.p. LPS and i.c.v. IL-1β injections, IL-1β expression was found in meningeal macrophages and parenchymal P2YR12+ microglia. Following CHI, IL-1β-expressing macrophages increased in the meninges and IL-1β-expressing microglia were induced in the parenchyma at the injury site and along white matter tracts.

Conclusions

This is the first time active populations of cytokine-expressing cells are visualized, characterized, and genetically accessed using a mouse line with a knockin CreER. With this tool, we identified the choroid plexus as the predominant IL-1β-expressing region in homeostasis. Further, this mouse can be used to identify newly activated IL-1β-expressing cells; they can be targeted for manipulation in physiological and pathological contexts.
背景:促炎细胞因子白细胞介素-1β (IL-1β)调节免疫功能的几乎所有方面。在大脑中,IL-1β在基础和炎症条件下都与神经和免疫功能有关。在基础条件下,已知IL-1β可以改变睡眠、记忆和情绪。在炎症条件下,IL-1β可诱导疾病行为,激活HPA,加重神经和心理障碍。对大脑中il -1β表达细胞的敏感检测和特异性操作目前还无法实现;因此,我们生成了第一个小鼠系,可以对表达il -1β的细胞进行强大的可视化和遗传操作。方法:通过crispr9介导重组,构建IL-1β-TRAP小鼠。将IRES-CreERT2插入il - 1b基因停止密码子后的第7外显子,得到il -1β- IRES-CreERT2小鼠(IL-1β-TRAP)。为了可视化il -1β表达细胞,将IL-1β-IRES-Cre-ERT2系与ROSA26-lox-stop-lox-tdTomato小鼠杂交,生成IL-1β-IRES-Cre-ERT2:ROSA26-lox-stop-lox-tdTomato (IL-1β-TRAP-reporter)。il -1β- trap报告基因小鼠腹腔注射。外周LPS或IL-1β给药前服用他莫昔芬。PBS作为对照。il -1β- trap报告小鼠也暴露于重复性闭闭性头部损伤(CHI)或ip kainic酸。tdTomato表达7d,通过免疫组织化学和/或光镜观察il -1β表达细胞的分布。结果:在基础条件下,IL-1β主要表达于MHCII+和CD206+脑膜和脑室巨噬细胞中,并在脑实质中稀疏表达IL-1β的小胶质细胞和神经元。LPS和腹腔注射IL-1β后,IL-1β在脑膜巨噬细胞和实质P2YR12+小胶质细胞中表达。CHI后,脑膜中表达il -1β的巨噬细胞增多,损伤部位实质和白质束中表达il -1β的小胶质细胞增多。结论:这是第一次使用敲入CreER的小鼠系来观察、表征和遗传获取表达细胞因子的活跃细胞群。通过这个工具,我们确定脉络膜丛是稳态中主要的il -1β表达区域。此外,该小鼠可用于鉴定新激活的il -1β表达细胞;它们可以在生理和病理背景下被操纵。
{"title":"Temporally-regulated genetic access to IL-1β-expressing cellular networks in homeostasis and following peripheral or central immune stimuli","authors":"Daniel P. Nemeth ,&nbsp;Xiaoyu Liu ,&nbsp;Loretta Chen ,&nbsp;Margaret R. Hawkins ,&nbsp;Haroon S. Ali ,&nbsp;Madison G. Lapid ,&nbsp;Vesal Farsian ,&nbsp;Ashley Kim ,&nbsp;Julianna Saez ,&nbsp;Gabriella Maxey ,&nbsp;Numana Luqman ,&nbsp;Samantha McGovern ,&nbsp;Matt Schrier ,&nbsp;Chris Vargas ,&nbsp;Josh St. Juste-Ellis ,&nbsp;Jasmine Yip ,&nbsp;Joris Romain ,&nbsp;Adam D. Bachstetter ,&nbsp;Ning Quan","doi":"10.1016/j.bbi.2025.106177","DOIUrl":"10.1016/j.bbi.2025.106177","url":null,"abstract":"<div><h3>Background</h3><div>The proinflammatory cytokine Interleukin-1 beta (IL-1β) regulates nearly all aspects of immune function. In the brain, IL-1β is implicated in neural and immune functions under both basal and inflammatory conditions. Under basal conditions, IL-1β is known to alter sleep, memory, and affect. Under inflammatory conditions, IL-1β can induce sickness behaviors, HPA activation, and exacerbate neurological and psychological disorders. Sensitive detection and specific manipulation of IL-1β-expressing cells in the brain is currently not achievable; therefore, we generated the first mouse line to allow both robust visualization and genetic manipulation of the IL-1β-expressing cells.</div></div><div><h3>Methods</h3><div>The IL-1β-TRAP mouse was generated through Crispr9-mediated recombination. IRES-CreER<sup>T2</sup> was inserted following exon 7 after the stop codon of the <em>Il1b</em> gene which yielded an IL-1β-IRES-Cre-ER<sup>T2</sup> mouse (IL-1β-TRAP). To visualize IL-1β-expressing cells, IL-1β-IRES-Cre-ER<sup>T2</sup> line was crossed with ROSA26-lox-stop-lox-tdTomato mouse to generate the IL-1β-IRES-Cre-ER<sup>T2</sup>:ROSA26-lox-stop-lox-tdTomato (IL-1β-TRAP-reporter). The IL-1β-TRAP-reporter mice were given intraperitoneal (i.p.) Tamoxifen before peripheral LPS or central IL-1β administration. PBS was used as control. The IL-1β-TRAP-reporter mice were also exposed to repetitive closed head injury (CHI) or i.p. kainic acid. tdTomato was allowed to express for 7d and distribution of IL-1β-expressing cells were observed via immunohistochemistry and/or lightsheet microscopy.</div></div><div><h3>Results</h3><div>Under basal conditions, IL-1β was found primarily to be expressed in MHCII<sup>+</sup> and CD206<sup>+</sup> meningeal and ventricular macrophages with sparse IL-1β-expressing microglia and neurons in brain parenchyma. Following i.p. LPS and i.c.v. IL-1β injections, IL-1β expression was found in meningeal macrophages and parenchymal P2YR12<sup>+</sup> microglia. Following CHI, IL-1β-expressing macrophages increased in the meninges and IL-1β-expressing microglia were induced in the parenchyma at the injury site and along white matter tracts.</div></div><div><h3>Conclusions</h3><div>This is the first time active populations of cytokine-expressing cells are visualized, characterized, and genetically accessed using a mouse line with a knockin CreER. With this tool, we identified the choroid plexus as the predominant IL-1β-expressing region in homeostasis. Further, this mouse can be used to identify newly activated IL-1β-expressing cells; they can be targeted for manipulation in physiological and pathological contexts.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"131 ","pages":"Article 106177"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sex differences in microglia morphology and function across the lifespan are mediated by the early hormone environment 小胶质细胞形态和功能在整个生命周期中的性别差异是由早期激素环境介导的。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106187
Lourdes K. Davis , Miranda M. Anders , Steven P. Guerin , Sophia E. Khoury , Lindsay M. Thompson , Jeffrey S. Darling , Andrea C. Gore , Laura K. Fonken
Microglia, the resident immune cell of the central nervous system (CNS), contribute to a range of physiological processes across the lifespan. Microglia exhibit notable sex differences in morphology, reactivity, and transcriptomic profiles. Steroid hormones in early life are believed to elicit sex differences in many cells, including microglia, in the CNS. However, few studies have examined how neonatal hormone environment impacts microglial morphology and function across the lifespan. Therefore, here we used steroid hormones to manipulate the early hormone environment to assess the appearance and persistence of sex differences in a rat model of healthy aging. Rat pups were dosed with steroid hormones on postnatal day (P)0 and 1: females received testosterone to “masculinize” them and males received flutamide, an androgen antagonist, to “feminize” them. Brain tissue was then collected at three distinct developmental timepoints: adolescence (P30), adulthood (P150), and aging (P700) for immunohistochemistry and ex vivo microglial stimulation. Transcriptomic changes in hippocampal tissue of aged animals were also assessed using 3’UTR biased transcriptome sequencing (Tag-seq). We report that testosterone treatment in females leads to lifelong alterations in body size and vaginal morphology and results in microglia that display a more “masculinized” phenotype compared to controls. Flutamide had more moderate effects on microglia morphology in males, contributing to a more “feminized” phenotype in the hippocampus in adult and aged males. Testosterone treatment also resulted in greater transcriptomic changes in the aged hippocampus compared to flutamide treatment, especially in genes related to mitochondrial function and inflammation. These results indicate that (1) early hormone environment is critical for the induction of sex differences in microglial morphology and (2) sex differences in microglial morphology reverse during aging, and this reversal is also recapitulated with early hormone treatment.
小胶质细胞是中枢神经系统(CNS)的常驻免疫细胞,在整个生命周期中参与一系列生理过程。小胶质细胞在形态、反应性和转录组谱上表现出显著的性别差异。据信,生命早期的类固醇激素会引起许多细胞的性别差异,包括中枢神经系统的小胶质细胞。然而,很少有研究调查了新生儿激素环境如何影响小胶质细胞的形态和功能。因此,在此,我们使用类固醇激素来操纵早期激素环境,以评估健康衰老大鼠模型中性别差异的出现和持久性。在出生后第0天和第1天给大鼠幼崽注射类固醇激素:雌性给睾酮使其“雄性化”,雄性给氟他胺(一种雄激素拮抗剂)使其“雌性化”。然后在三个不同的发育时间点收集脑组织:青春期(P30),成年期(P150)和衰老期(P700),用于免疫组织化学和体外小胶质细胞刺激。使用3'UTR偏倚转录组测序(Tag-seq)评估老年动物海马组织的转录组变化。我们报道,在女性中,睾酮治疗导致终生的体型和阴道形态改变,并导致小胶质细胞与对照组相比显示出更“男性化”的表型。氟他胺对雄性小胶质细胞形态的影响更温和,导致成年和老年雄性海马中更“女性化”的表型。与氟他胺治疗相比,睾酮治疗还导致老年海马中更大的转录组变化,特别是与线粒体功能和炎症相关的基因。这些结果表明:(1)早期激素环境对诱导小胶质细胞形态的性别差异至关重要;(2)随着年龄的增长,小胶质细胞形态的性别差异会逆转,这种逆转也会在早期激素治疗中重现。
{"title":"Sex differences in microglia morphology and function across the lifespan are mediated by the early hormone environment","authors":"Lourdes K. Davis ,&nbsp;Miranda M. Anders ,&nbsp;Steven P. Guerin ,&nbsp;Sophia E. Khoury ,&nbsp;Lindsay M. Thompson ,&nbsp;Jeffrey S. Darling ,&nbsp;Andrea C. Gore ,&nbsp;Laura K. Fonken","doi":"10.1016/j.bbi.2025.106187","DOIUrl":"10.1016/j.bbi.2025.106187","url":null,"abstract":"<div><div>Microglia, the resident immune cell of the central nervous system (CNS), contribute to a range of physiological processes across the lifespan. Microglia exhibit notable sex differences in morphology, reactivity, and transcriptomic profiles. Steroid hormones in early life are believed to elicit sex differences in many cells, including microglia, in the CNS. However, few studies have examined how neonatal hormone environment impacts microglial morphology and function across the lifespan. Therefore, here we used steroid hormones to manipulate the early hormone environment to assess the appearance and persistence of sex differences in a rat model of healthy aging. Rat pups were dosed with steroid hormones on postnatal day (P)0 and 1: females received testosterone to “masculinize” them and males received flutamide, an androgen antagonist, to “feminize” them. Brain tissue was then collected at three distinct developmental timepoints: adolescence (P30), adulthood (P150), and aging (P700) for immunohistochemistry and <em>ex vivo</em> microglial stimulation. Transcriptomic changes in hippocampal tissue of aged animals were also assessed using 3’UTR biased transcriptome sequencing (Tag-seq). We report that testosterone treatment in females leads to lifelong alterations in body size and vaginal morphology and results in microglia that display a more “masculinized” phenotype compared to controls. Flutamide had more moderate effects on microglia morphology in males, contributing to a more “feminized” phenotype in the hippocampus in adult and aged males. Testosterone treatment also resulted in greater transcriptomic changes in the aged hippocampus compared to flutamide treatment, especially in genes related to mitochondrial function and inflammation. These results indicate that (1) early hormone environment is critical for the induction of sex differences in microglial morphology and (2) sex differences in microglial morphology reverse during aging, and this reversal is also recapitulated with early hormone treatment.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"132 ","pages":"Article 106187"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autophagy activation by the Becn1F121A mutation reprograms neuroinflammation and promotes neurological recovery after spinal cord injury Becn1F121A突变激活自噬,重编程神经炎症,促进脊髓损伤后神经系统恢复。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106191
Zhuofan Lei, Yun Li, Hui Li, Junfang Wu
Autophagy is essential for maintaining cellular homeostasis, particularly under stress conditions such as neurotrauma. In experimental models of spinal cord injury (SCI), dysregulated autophagy has been closely associated with secondary injury cascades. Our previous work demonstrated that post-injury inflammation is exacerbated by genetic inhibition of autophagy and alleviated by pharmacological enhancement. Emerging evidence also indicates that SCI can induce neuropathological changes in the brain, leading to cognitive impairments; however, the underlying molecular mechanisms remain largely unclear. In this study, we utilized Becn1F121A/F121A knock-in (BMut) mice to investigate how genetically enhanced autophagy influences transcriptomic profiles, neural cell responses, tissue pathology, and functional recovery following contusion SCI. Transcriptomic analysis of BMut mouse spinal cord (SPC) tissues at 3 days post-injury revealed enhanced autophagy flux, reduced inflammatory responses, and altered microglial function and immune activity. Ten weeks after injury, BMut mice exhibited distinct transcriptomic profiles in the SPC, somatosensory cortex, and hippocampus. Further analyses revealed that the Becn1F121A/F121A mutation enhanced autophagy and altered inflammatory responses to SCI across all three regions. Behavioral assessments demonstrated improved functional recovery in BMut mice, accompanied by better-preserved spared white matter and reduced lesion volume. Immunofluorescence staining analysis showed that the Becn1F121A/F121A mutation reduced microglial activation and enhanced neurogenesis in the hippocampal dentate gyrus. Our study showed that genetic enhancement of autophagy altered transcriptomic responses, particularly inflammation, after SCI, reducing neuropathology in the spinal cord and brain and improving function. This is the first evidence linking autophagy enhancement to modulation of neuroinflammation after SCI, highlighting its therapeutic potential.
自噬对于维持细胞稳态至关重要,特别是在神经创伤等应激条件下。在脊髓损伤(SCI)的实验模型中,自噬失调与继发性损伤级联反应密切相关。我们之前的研究表明,自噬的遗传抑制加剧了损伤后的炎症,并通过药物增强减轻了炎症。新的证据还表明,脊髓损伤可引起大脑神经病理改变,导致认知障碍;然而,潜在的分子机制在很大程度上仍不清楚。在这项研究中,我们利用Becn1F121A/F121A敲入(BMut)小鼠来研究基因增强的自噬如何影响挫伤性脊髓损伤后的转录组学特征、神经细胞反应、组织病理和功能恢复。损伤后3 天对BMut小鼠脊髓(SPC)组织的转录组学分析显示,自噬通量增强,炎症反应减少,小胶质细胞功能和免疫活性改变。损伤后10周,BMut小鼠在SPC、体感觉皮层和海马中表现出不同的转录组谱。进一步的分析显示,Becn1F121A/F121A突变增强了所有三个区域的自噬并改变了对脊髓损伤的炎症反应。行为评估表明,BMut小鼠的功能恢复得到改善,同时保留的白质更好,病变体积减少。免疫荧光染色分析显示,Becn1F121A/F121A突变降低了海马齿状回的小胶质细胞激活,增强了神经发生。我们的研究表明,基因增强的自噬改变了脊髓损伤后的转录组反应,特别是炎症,减少了脊髓和大脑的神经病理,改善了功能。这是第一个将自噬增强与脊髓损伤后神经炎症调节联系起来的证据,突出了其治疗潜力。
{"title":"Autophagy activation by the Becn1F121A mutation reprograms neuroinflammation and promotes neurological recovery after spinal cord injury","authors":"Zhuofan Lei,&nbsp;Yun Li,&nbsp;Hui Li,&nbsp;Junfang Wu","doi":"10.1016/j.bbi.2025.106191","DOIUrl":"10.1016/j.bbi.2025.106191","url":null,"abstract":"<div><div>Autophagy is essential for maintaining cellular homeostasis, particularly under stress conditions such as neurotrauma. In experimental models of spinal cord injury (SCI), dysregulated autophagy has been closely associated with secondary injury cascades. Our previous work demonstrated that post-injury inflammation is exacerbated by genetic inhibition of autophagy and alleviated by pharmacological enhancement. Emerging evidence also indicates that SCI can induce neuropathological changes in the brain, leading to cognitive impairments; however, the underlying molecular mechanisms remain largely unclear. In this study, we utilized Becn1<sup>F121A/F121A</sup> knock-in (BMut) mice to investigate how genetically enhanced autophagy influences transcriptomic profiles, neural cell responses, tissue pathology, and functional recovery following contusion SCI. Transcriptomic analysis of BMut mouse spinal cord (SPC) tissues at 3 days post-injury revealed enhanced autophagy flux, reduced inflammatory responses, and altered microglial function and immune activity. Ten weeks after injury, BMut mice exhibited distinct transcriptomic profiles in the SPC, somatosensory cortex, and hippocampus. Further analyses revealed that the Becn1<sup>F121A/F121A</sup> mutation enhanced autophagy and altered inflammatory responses to SCI across all three regions. Behavioral assessments demonstrated improved functional recovery in BMut mice, accompanied by better-preserved spared white matter and reduced lesion volume. Immunofluorescence staining analysis showed that the Becn1<sup>F121A/F121A</sup> mutation reduced microglial activation and enhanced neurogenesis in the hippocampal dentate gyrus. Our study showed that genetic enhancement of autophagy altered transcriptomic responses, particularly inflammation, after SCI, reducing neuropathology in the spinal cord and brain and improving function. This is the first evidence linking autophagy enhancement to modulation of neuroinflammation after SCI, highlighting its therapeutic potential.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"131 ","pages":"Article 106191"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145572968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Searching for blood biomarkers and treatment targets in Women with fibromyalgia – Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates 寻找女性纤维肌痛患者的血液生物标志物和治疗靶点-蛋白质相互作用模式和抗卫星胶质细胞IgG抗体是有希望的候选人。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106185
Karolina af Ekenstam , Joana Menezes , Jenny E. Jakobsson , Helene Silverstein , Emerson Krock , Jeanette Tour , Katalin Sandor , Alexandra Kuliszkiewicz , Matthew Hunt , Kim Kultima , Macarena Tejos-Bravo , Camilla I. Svensson , Eva Kosek

Background

Recent studies suggest that autoreactive immunoglobulin G (IgG) antibodies binding to satellite glia cells (anti-SGC IgG) in the dorsal root ganglia influence pain intensity in a subgroup of fibromyalgia subjects (FMS), thus indicating altered immune activation. The main aim of this study was to identify proteins distinguishing female FMS from female healthy controls (HC) and within the FM group, proteins distinguishing FMS with high vs low levels of anti-SGC IgG. The secondary aim was to assess the associations between serum proteins and anti-SGC IgG, respectively, and FM symptoms.

Methods

Anti-SGC IgG was quantified using an immunofluorescence assay. Proteins in serum were assessed using Olink® Explore 384 Inflammation panel, regarding differences between FMS (n = 93) and HC (n = 40) and regarding differences between FMS with high (≥50 %) and low (<50 %) anti-SGC IgG, respectively. Proteins found to differ between groups (VIP ≥ 1.3) were further analyzed regarding protein-interactions using the software tool STRING (FM vs HC n = 56, high vs low anti-SGC IgG n = 55). Results from the FM group were also compared with two nociceptive pain conditions.

Results

In FMS, a cluster of immune system-related proteins was found among upregulated proteins, including CD40 and CD40L, with central roles in humoral immune response. CD40 levels were associated with more severe FM symptoms. In contrast, a cluster of tissue development-/regeneration-related proteins was found among downregulated proteins, this was not seen in nociceptive pain conditions. In FMS with high anti-SGC IgG, clusters dominated by immune system-related proteins were found among both upregulated and downregulated proteins. The cluster of upregulated proteins included CD79b, a protein necessary for B-cell receptor function, and CD4, a co receptor needed for T cell activation, thus with central role in activating various immune responses, including B-cell activation. Positive correlations were seen between some of these proteins and symptoms. On the contrary, several of the downregulated proteins correlated negatively to symptoms.

Conclusion

Our data support the involvement of the immune system in FM and indicate that further studies on autoimmune mechanisms, proteomics, and protein interaction analysis could lead to new objective diagnostic criteria identifying FMS likely to benefit from immunomodulatory treatments.
背景:最近的研究表明,与背根神经节卫星神经胶质细胞结合的自身反应性免疫球蛋白G (IgG)抗体(抗sgc IgG)影响纤维肌痛患者(FMS)亚群的疼痛强度,从而表明免疫激活改变。本研究的主要目的是鉴定区分女性FMS与女性健康对照组(HC)的蛋白质,以及在FM组中区分FMS与高水平和低水平抗sgc IgG的蛋白质。第二个目的是评估血清蛋白和抗sgc IgG分别与FM症状之间的关系。方法:采用免疫荧光法定量测定抗sgc IgG。使用Olink®Explore 384炎症面板评估血清蛋白,关于FMS (n = 93)和HC (n = 40)之间的差异,以及FMS高(≥50 %)和低(结果:在FMS中,在上调蛋白中发现了一组免疫系统相关蛋白,包括CD40和CD40L,在体液免疫反应中起核心作用。CD40水平与更严重的FM症状相关。相反,在下调的蛋白中发现了一组组织发育/再生相关蛋白,这在痛觉性疼痛条件下未见。在高抗sgc IgG的FMS中,在上调和下调的蛋白中都发现了以免疫系统相关蛋白为主的簇。这组上调的蛋白包括CD79b (b细胞受体功能必需的蛋白)和CD4 (T细胞激活所需的辅助受体),因此在激活包括b细胞激活在内的各种免疫反应中起着核心作用。其中一些蛋白质与症状之间存在正相关。相反,一些下调的蛋白与症状呈负相关。结论:我们的数据支持免疫系统参与FM,并表明对自身免疫机制、蛋白质组学和蛋白质相互作用分析的进一步研究可能会导致新的客观诊断标准,确定FMS可能受益于免疫调节治疗。
{"title":"Searching for blood biomarkers and treatment targets in Women with fibromyalgia – Protein interaction patterns and anti-satellite glia cell IgG antibodies as promising candidates","authors":"Karolina af Ekenstam ,&nbsp;Joana Menezes ,&nbsp;Jenny E. Jakobsson ,&nbsp;Helene Silverstein ,&nbsp;Emerson Krock ,&nbsp;Jeanette Tour ,&nbsp;Katalin Sandor ,&nbsp;Alexandra Kuliszkiewicz ,&nbsp;Matthew Hunt ,&nbsp;Kim Kultima ,&nbsp;Macarena Tejos-Bravo ,&nbsp;Camilla I. Svensson ,&nbsp;Eva Kosek","doi":"10.1016/j.bbi.2025.106185","DOIUrl":"10.1016/j.bbi.2025.106185","url":null,"abstract":"<div><h3>Background</h3><div>Recent studies suggest that autoreactive immunoglobulin G (IgG) antibodies binding to satellite glia cells (anti-SGC IgG) in the dorsal root ganglia influence pain intensity in a subgroup of fibromyalgia subjects (FMS), thus indicating altered immune activation. The main aim of this study was to identify proteins distinguishing female FMS from female healthy controls (HC) and within the FM group, proteins distinguishing FMS with high vs low levels of anti-SGC IgG. The secondary aim was to assess the associations between serum proteins and anti-SGC IgG, respectively, and FM symptoms.</div></div><div><h3>Methods</h3><div>Anti-SGC IgG was quantified using an immunofluorescence assay. Proteins in serum were assessed using Olink® Explore 384 Inflammation panel, regarding differences between FMS (n = 93) and HC (n = 40) and regarding differences between FMS with high (≥50 %) and low (&lt;50 %) anti-SGC IgG, respectively. Proteins found to differ between groups (VIP ≥ 1.3) were further analyzed regarding protein-interactions using the software tool STRING (FM vs HC n = 56, high vs low anti-SGC IgG n = 55). Results from the FM group were also compared with two nociceptive pain conditions.</div></div><div><h3>Results</h3><div>In FMS, a cluster of immune system-related proteins was found among upregulated proteins, including CD40 and CD40L, with central roles in humoral immune response. CD40 levels were associated with more severe FM symptoms. In contrast, a cluster of tissue development-/regeneration-related proteins was found among downregulated proteins, this was not seen in nociceptive pain conditions. In FMS with high anti-SGC IgG, clusters dominated by immune system-related proteins were found among both upregulated and downregulated proteins. The cluster of upregulated proteins included CD79b, a protein necessary for B-cell receptor function, and CD4, a co receptor needed for T cell activation, thus with central role in activating various immune responses, including B-cell activation. Positive correlations were seen between some of these proteins and symptoms. On the contrary, several of the downregulated proteins correlated negatively to symptoms.</div></div><div><h3>Conclusion</h3><div>Our data support the involvement of the immune system in FM and indicate that further studies on autoimmune mechanisms, proteomics, and protein interaction analysis could lead to new objective diagnostic criteria identifying FMS likely to benefit from immunomodulatory treatments.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"132 ","pages":"Article 106185"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573069","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cathepsin B overexpression and lysosomal leakage in inflammatory microglia promote neuroinflammation in olfactory dysfunction by triggering mitochondrial dysfunction and pyroptosis 炎性小胶质细胞组织蛋白酶B过表达和溶酶体渗漏通过触发线粒体功能障碍和焦亡促进嗅觉功能障碍的神经炎症。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106188
Huiqin Zhou , Li Wang , Yuanyuan Yang , Fangzhou Ye , Xuanyu Zhao , Kesen Zhu , Ziheng Huang , Wei Lv , Hongmeng Yu
Olfactory dysfunction (OD) is a common sensory disorder with age-related prevalence and serves as an early clinical manifestation for neurodegenerative and inflammatory diseases. Microglia in the olfactory bulb (OB) rapidly respond to olfactory injury and initiate immune responses, but the cell state dynamics and pathways driving OD remain poorly understood. Here, we performed single-cell RNA sequencing of mouse OBs at 0, 7, and 30 days post olfactory injury, and identified 3 distinct microglial states including inflammatory, negative regulatory, and homeostatic. The inflammatory microglia exacerbated neuroinflammation by secreting cytokines and chemokines that recruited immune cells and amplify local immune responses. Cathepsin B was identified as a key regulator of this inflammatory microglial activity. In vitro studies using BV2 and primary microglia demonstrated that both pharmacological inhibition and genetic deletion of CTSB attenuated lipopolysaccharide (LPS)-induced mitochondrial dysfunction, NLRP3 activation, and pro-inflammatory cytokine release. In mice with OD, pharmacological inhibition of CTSB with CA074me promoted olfactory function recovery and modulated microglial pro-inflammatory responses. Our findings uncover inflammation-associated microglial subpopulations enriched in OD and unveiled a deleterious role for CTSB-mediated neuroinflammatory signaling in OD pathogenesis. Targeting CTSB may therefore serve as a promising therapeutic strategy to mitigate microglia-mediated neuroinflammation and facilitate olfactory recovery in OD.
嗅觉功能障碍(OD)是一种常见的与年龄相关的感觉障碍,是神经退行性和炎症性疾病的早期临床标志。嗅球(OB)中的小胶质细胞对嗅觉损伤迅速反应并启动免疫反应,但细胞状态动力学和驱动OD的途径尚不清楚。在这里,我们对嗅觉损伤后0、7和30天的小鼠OBs进行了单细胞RNA测序,确定了3种不同的小胶质细胞状态,包括炎症、负调节和稳态。炎性小胶质细胞通过分泌细胞因子和趋化因子来招募免疫细胞并放大局部免疫反应,从而加剧了神经炎症。组织蛋白酶B被认为是炎症性小胶质细胞活性的关键调节因子。利用BV2和原代小胶质细胞进行的体外研究表明,CTSB的药理抑制和基因缺失均可减轻脂多糖(LPS)诱导的线粒体功能障碍、NLRP3激活和促炎细胞因子释放。在OD小鼠中,CA074me对CTSB的药理学抑制促进了嗅觉功能的恢复,并调节了小胶质细胞的促炎反应。我们的研究结果揭示了炎症相关的小胶质细胞亚群在OD中富集,并提示ctsb介导的神经炎症信号在OD发病机制中的有害作用。靶向CTSB可能是一种很有前途的治疗策略,可以减轻小胶质细胞介导的神经炎症,促进嗅觉恢复。嗅觉功能障碍(OD)是一种常见的与年龄相关的感觉障碍,是神经退行性和炎症性疾病的早期临床标志。嗅球(OB)中的小胶质细胞对嗅觉损伤迅速反应并启动免疫反应,但细胞状态动力学和驱动OD的途径尚不清楚。在这里,我们对嗅觉损伤后0、7和30天的小鼠OBs进行了单细胞RNA测序,确定了3种不同的小胶质细胞状态,包括炎症、负调节和稳态。炎性小胶质细胞通过分泌细胞因子和趋化因子来招募免疫细胞并放大局部免疫反应,从而加剧了神经炎症。组织蛋白酶B被认为是炎症性小胶质细胞活性的关键调节因子。利用BV2小胶质细胞进行的体外研究表明,CTSB的药理抑制和基因缺失均可减轻脂多糖(LPS)诱导的线粒体功能障碍、NLRP3激活和促炎细胞因子释放。在OD小鼠中,CA074me对CTSB的药理学抑制促进了嗅觉功能的恢复,并调节了小胶质细胞的促炎反应。我们的研究结果揭示了炎症相关的小胶质细胞亚群在OD中富集,并提示ctsb介导的神经炎症信号在OD发病机制中的有害作用。靶向CTSB可能是一种很有前途的治疗策略,可以减轻小胶质细胞介导的神经炎症,促进嗅觉恢复。
{"title":"Cathepsin B overexpression and lysosomal leakage in inflammatory microglia promote neuroinflammation in olfactory dysfunction by triggering mitochondrial dysfunction and pyroptosis","authors":"Huiqin Zhou ,&nbsp;Li Wang ,&nbsp;Yuanyuan Yang ,&nbsp;Fangzhou Ye ,&nbsp;Xuanyu Zhao ,&nbsp;Kesen Zhu ,&nbsp;Ziheng Huang ,&nbsp;Wei Lv ,&nbsp;Hongmeng Yu","doi":"10.1016/j.bbi.2025.106188","DOIUrl":"10.1016/j.bbi.2025.106188","url":null,"abstract":"<div><div>Olfactory dysfunction (OD) is a common sensory disorder with age-related prevalence and serves as an early clinical manifestation for neurodegenerative and inflammatory diseases. Microglia in the olfactory bulb (OB) rapidly respond to olfactory injury and initiate immune responses, but the cell state dynamics and pathways driving OD remain poorly understood. Here, we performed single-cell RNA sequencing of mouse OBs at 0, 7, and 30 days post olfactory injury, and identified 3 distinct microglial states including inflammatory, negative regulatory, and homeostatic.<!--> <!-->The inflammatory microglia exacerbated neuroinflammation by secreting cytokines and chemokines that recruited immune cells and amplify local immune responses. Cathepsin B was identified as a key regulator of this inflammatory microglial activity. In vitro studies using BV2 and primary microglia demonstrated that both pharmacological inhibition and genetic deletion of CTSB attenuated lipopolysaccharide (LPS)-induced mitochondrial dysfunction, NLRP3 activation, and pro-inflammatory cytokine release. In mice with OD, pharmacological inhibition of CTSB with CA074me promoted olfactory function recovery and modulated microglial pro-inflammatory responses. Our findings uncover inflammation-associated microglial subpopulations enriched in OD and unveiled a deleterious role for CTSB-mediated neuroinflammatory signaling in OD pathogenesis. Targeting CTSB may therefore serve as a promising therapeutic strategy to mitigate microglia-mediated neuroinflammation and facilitate olfactory recovery in OD.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"132 ","pages":"Article 106188"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145572971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study on the efficacy and mechanism of fecal microbiota transplantation for depression based on circadian rhythm 基于昼夜节律的粪便微生物群移植治疗抑郁症的疗效及机制研究。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106186
Pengpeng Cao , Yuhao Li , Shuo Zhang, Chuying Li, Yanzhuang Sun, Bei An

Background

Depression is closely associated with disruptions in circadian rhythms, and emerging evidence highlights critical roles of gut dysbiosis in its pathogenesis. However, the mechanisms by which FMT chronotherapy influences circadian gene in depression—via gut microbiota—remain poorly understood.

Methods

In this study, we established a chronic unpredictable mild stress (CUMS) mouse model and performed fecal microbiota transplantation (FMT) using donor microbiota from healthy mice at two distinct circadian time points-zeitgeber time (ZT) 4 or ZT16 to identify the optimal timing for FMT based on behavioral assessments. Integrating omics dependent mechanisms of antidepressant effects mediated by these key functional bacteria.

Results

Health-FMT significantly alleviated depressive-like behaviors, with superior efficacy at ZT4. It restored circadian gene expressions and attenuated neuroinflammation expression in the hippocampus and prefrontal cortex. 16S rRNA sequencing revealed that Health-FMT reduced uncultured_bacterium_g_Alistipes abundance, a genus linked to tryptophan availability. Tryptophan supplementation regulated circadian gene expressions, inflammatory factors, brain-derived neurotrophic factors (BDNF), microglial and astrocytic activation, and exerted antidepressant effects via the ERK signaling pathway.

Conclusions

These findings suggest that Health-FMT exerts antidepressant effects by restoring gut homeostasis, particularly by reducing Alistipes, thereby rebalancing tryptophan metabolic and circadian gene expressions. These findings offer a new possible mechanism and novel insights into the microbiota-gut-brain axis in depression, and underscore the importance of chronotherapy in FMT-based therapeutic strategies.
背景:抑郁症与昼夜节律紊乱密切相关,新出现的证据强调了肠道生态失调在其发病机制中的关键作用。然而,FMT时间疗法通过肠道微生物群影响抑郁症昼夜节律基因的机制仍然知之甚少。方法:在本研究中,我们建立了慢性不可预测轻度应激(CUMS)小鼠模型,并在两个不同的昼夜节律时间点(zeitgeber时间(ZT) 4或ZT16)使用健康小鼠的供体微生物群进行粪便微生物群移植(FMT),以确定基于行为评估的最佳时间进行FMT。整合这些关键功能细菌介导的抗抑郁作用的组学依赖机制。结果:健康- fmt可显著缓解抑郁样行为,且在ZT4时效果更佳。它恢复了海马和前额皮质的昼夜节律基因表达,减弱了神经炎症表达。16S rRNA测序显示,Health-FMT减少了未培养细菌的丰度,这是一个与色氨酸可用性相关的属。补充色氨酸调节昼夜基因表达、炎症因子、脑源性神经营养因子(BDNF)、小胶质细胞和星形胶质细胞活化,并通过ERK信号通路发挥抗抑郁作用。结论:这些发现表明,健康- fmt通过恢复肠道稳态,特别是通过减少Alistipes,从而重新平衡色氨酸代谢和昼夜节律基因表达,发挥抗抑郁作用。这些发现为抑郁症的微生物-肠道-脑轴提供了新的可能机制和新的见解,并强调了时间疗法在基于fmt的治疗策略中的重要性。
{"title":"Study on the efficacy and mechanism of fecal microbiota transplantation for depression based on circadian rhythm","authors":"Pengpeng Cao ,&nbsp;Yuhao Li ,&nbsp;Shuo Zhang,&nbsp;Chuying Li,&nbsp;Yanzhuang Sun,&nbsp;Bei An","doi":"10.1016/j.bbi.2025.106186","DOIUrl":"10.1016/j.bbi.2025.106186","url":null,"abstract":"<div><h3>Background</h3><div>Depression is closely associated with disruptions in circadian rhythms, and emerging evidence highlights critical roles of gut dysbiosis in its pathogenesis. However, the mechanisms by which FMT chronotherapy influences circadian gene in depression—via gut microbiota—remain poorly understood.</div></div><div><h3>Methods</h3><div>In this study, we established a chronic unpredictable mild stress (CUMS) mouse model and performed fecal microbiota transplantation (FMT) using donor microbiota from healthy mice at two distinct circadian time points-zeitgeber time (ZT) 4 or ZT16 to identify the optimal timing for FMT based on behavioral assessments. Integrating omics dependent mechanisms of antidepressant effects mediated by these key functional bacteria.</div></div><div><h3>Results</h3><div>Health-FMT significantly alleviated depressive-like behaviors, with superior efficacy at ZT4. It restored circadian gene expressions and attenuated neuroinflammation expression in the hippocampus and prefrontal cortex. 16S rRNA sequencing revealed that Health-FMT reduced <em>uncultured_bacterium_g_Alistipes</em> abundance, a genus linked to tryptophan availability. Tryptophan supplementation regulated circadian gene expressions, inflammatory factors, brain-derived neurotrophic factors (BDNF), microglial and astrocytic activation, and exerted antidepressant effects via the ERK signaling pathway.</div></div><div><h3>Conclusions</h3><div>These findings suggest that Health-FMT exerts antidepressant effects by restoring gut homeostasis, particularly by reducing <em>Alistipes</em>, thereby rebalancing tryptophan metabolic and circadian gene expressions. These findings offer a new possible mechanism and novel insights into the microbiota-gut-brain axis in depression, and underscore the importance of chronotherapy in FMT-based therapeutic strategies.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"131 ","pages":"Article 106186"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145562884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In utero exposure to anti-Caspr2 antibody disrupts parvalbumin interneuron function in the hippocampus 子宫内暴露于抗caspr2抗体可破坏海马小白蛋白中间神经元功能。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106192
Ciara Bagnall-Moreau , Joshua J. Strohl , Benjamin Spielman , Christian Cruz , Patricio Huerta , Lior Brimberg
Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by deficits in communication and social interaction and may stem from an imbalance between excitatory and inhibitory (E/I) signaling in neural circuits. Parvalbumin-expressing (PV+) interneurons are crucial for maintaining E/I balance and regulating network oscillations. Alterations in the number of PV+ interneurons or reductions in PV expression have been observed in both the postmortem brains of individuals with ASD and in animal models, including those induced by in utero exposure to maternal brain-reactive antibodies. In this study, we investigate the impact of in utero exposure to maternal anti-Caspr2 IgG on PV+ interneuron development and function in the hippocampus. Our results demonstrate a selective reduction in PV+ interneurons and perisomatic inhibitory synapses in the hippocampal CA1 region of juvenile and adult male offspring exposed in utero to anti-Caspr2 antibodies compared to controls. Additionally, local field potential (LFP) recordings from these mice show increased gamma power and altered neuronal firing patterns during social interactions, indicating functional impairments in inhibitory circuitry. These findings highlight the consequences of exposure to maternal anti-Caspr2 antibodies on PV+ interneuron development and function, providing insights into the neurobiological mechanisms underlying ASD associated behavioral phenotypes.
自闭症谱系障碍(ASD)是一种复杂的神经发育疾病,其特征是沟通和社会互动的缺陷,可能源于神经回路中兴奋性和抑制性(E/I)信号的不平衡。小蛋白表达(PV+)的中间神经元对于维持E/I平衡和调节网络振荡至关重要。在ASD患者死后的大脑和动物模型中,包括在子宫内暴露于母体脑反应性抗体诱导的动物模型中,均观察到PV+中间神经元数量的改变或PV表达的减少。在这项研究中,我们研究了子宫内暴露于母体抗caspr2 IgG对海马PV+中间神经元发育和功能的影响。我们的研究结果表明,与对照组相比,在子宫内暴露于抗caspr2抗体的幼年和成年雄性后代海马CA1区域的PV+中间神经元和胞周抑制性突触选择性减少。此外,来自这些小鼠的局部场电位(LFP)记录显示,在社交互动中,伽马能量增加,神经元放电模式改变,表明抑制回路的功能受损。这些发现强调了暴露于母体抗caspr2抗体对PV+中间神经元发育和功能的影响,为ASD相关行为表型的神经生物学机制提供了见解。
{"title":"In utero exposure to anti-Caspr2 antibody disrupts parvalbumin interneuron function in the hippocampus","authors":"Ciara Bagnall-Moreau ,&nbsp;Joshua J. Strohl ,&nbsp;Benjamin Spielman ,&nbsp;Christian Cruz ,&nbsp;Patricio Huerta ,&nbsp;Lior Brimberg","doi":"10.1016/j.bbi.2025.106192","DOIUrl":"10.1016/j.bbi.2025.106192","url":null,"abstract":"<div><div>Autism Spectrum Disorder (ASD) is a complex neurodevelopmental condition characterized by deficits in communication and social interaction and may stem from an imbalance between excitatory and inhibitory (E/I) signaling in neural circuits. Parvalbumin-expressing (PV+) interneurons are crucial for maintaining E/I balance and regulating network oscillations. Alterations in the number of PV+ interneurons or reductions in PV expression have been observed in both the postmortem brains of individuals with ASD and in animal models, including those induced by in utero exposure to maternal brain-reactive antibodies. In this study, we investigate the impact of in utero exposure to maternal anti-Caspr2 IgG on PV+ interneuron development and function in the hippocampus. Our results demonstrate a selective reduction in PV+ interneurons and perisomatic inhibitory synapses in the hippocampal CA1 region of juvenile and adult male offspring exposed in utero to anti-Caspr2 antibodies compared to controls. Additionally, local field potential (LFP) recordings from these mice show increased gamma power and altered neuronal firing patterns during social interactions, indicating functional impairments in inhibitory circuitry. These findings highlight the consequences of exposure to maternal anti-Caspr2 antibodies on PV+ interneuron development and function, providing insights into the neurobiological mechanisms underlying ASD associated behavioral phenotypes.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"132 ","pages":"Article 106192"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cerebral ischaemic stroke results in altered mucosal antibody responses and host-commensal microbiota interactions 脑缺血性中风导致粘膜抗体反应和宿主-共生微生物群相互作用的改变。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106184
Madeleine Hurry , David A. Posner , Raymond Wong , Alba Grayston , Laura Díaz-Marugan , Xiaotong Zhang , Bianca De Leon , Corinne Benakis , Ari Waisman , Laura McCulloch , Stuart M. Allan , Catherine B. Lawrence , David Brough , Matthew R. Hepworth
Stroke is a devastating neurological event with a high risk of mortality that results in long-term sequalae that extend beyond the central nervous system. Notably these include gastrointestinal dysfunction and altered composition of the commensal microbiota in both patients and mouse models, which have been suggested to contribute to secondary infection and poor clinical outcomes following stroke. Strikingly, changes in commensal microbial community composition occur rapidly following stroke and correlate with disease severity. Despite these observations, the underpinning mechanisms that drive perturbation of the microbiota post-stroke remain poorly understood. The gastrointestinal tract is home to a complex network of tissue-resident immune cells that maintain homeostatic interactions with commensal microbes and prevent bacterial-driven inflammation. Here we demonstrate mice subjected to ischaemic stroke exhibit alterations in the intestinal immune system, most notably in class switched germinal centre B cells and the production of Immunoglobulin A (IgA) – a major effector response against commensal microbes. Mice lacking secretory antibodies, including IgA, exhibited a partial reversion of stroke-induced changes in microbiota composition. Together these findings demonstrate stroke is associated with dysregulation of antibody producing immune responses, which may in part explain changes in the intestinal microbiota. A mechanistic understanding of the immunological basis of stroke-associated pathologies in the periphery may open new avenues to manage the secondary complications and long-term prognosis of patients suffering from neurological disease.
中风是一种毁灭性的神经系统事件,死亡率高,其长期后遗症会延伸到中枢神经系统以外。值得注意的是,在患者和小鼠模型中,这些包括胃肠道功能障碍和共生微生物群组成的改变,这被认为是中风后继发感染和不良临床结果的原因。值得注意的是,共生微生物群落组成的变化在中风后迅速发生,并与疾病严重程度相关。尽管有这些观察结果,驱动中风后微生物群扰动的基本机制仍然知之甚少。胃肠道是组织驻留免疫细胞的复杂网络的家园,这些细胞与共生微生物保持稳态相互作用,防止细菌驱动的炎症。在这里,我们证明了遭受缺血性中风的小鼠在肠道免疫系统中表现出改变,最明显的是在类切换生发中心B细胞和免疫球蛋白A (IgA)的产生-免疫球蛋白A (IgA)是一种针对共生微生物的主要效应反应。缺乏分泌抗体(包括IgA)的小鼠在中风引起的微生物群组成变化中表现出部分逆转。总之,这些发现表明中风与抗体产生免疫反应的失调有关,这可能在一定程度上解释了肠道微生物群的变化。神经系统疾病患者继发性并发症的处理和长期预后的研究可能会为神经系统疾病患者的免疫基础机制的理解开辟新的途径。
{"title":"Cerebral ischaemic stroke results in altered mucosal antibody responses and host-commensal microbiota interactions","authors":"Madeleine Hurry ,&nbsp;David A. Posner ,&nbsp;Raymond Wong ,&nbsp;Alba Grayston ,&nbsp;Laura Díaz-Marugan ,&nbsp;Xiaotong Zhang ,&nbsp;Bianca De Leon ,&nbsp;Corinne Benakis ,&nbsp;Ari Waisman ,&nbsp;Laura McCulloch ,&nbsp;Stuart M. Allan ,&nbsp;Catherine B. Lawrence ,&nbsp;David Brough ,&nbsp;Matthew R. Hepworth","doi":"10.1016/j.bbi.2025.106184","DOIUrl":"10.1016/j.bbi.2025.106184","url":null,"abstract":"<div><div>Stroke is a devastating neurological event with a high risk of mortality that results in long-term sequalae that extend beyond the central nervous system. Notably these include gastrointestinal dysfunction and altered composition of the commensal microbiota in both patients and mouse models, which have been suggested to contribute to secondary infection and poor clinical outcomes following stroke. Strikingly, changes in commensal microbial community composition occur rapidly following stroke and correlate with disease severity. Despite these observations, the underpinning mechanisms that drive perturbation of the microbiota post-stroke remain poorly understood. The gastrointestinal tract is home to a complex network of tissue-resident immune cells that maintain homeostatic interactions with commensal microbes and prevent bacterial-driven inflammation. Here we demonstrate mice subjected to ischaemic stroke exhibit alterations in the intestinal immune system, most notably in class switched germinal centre B cells and the production of Immunoglobulin A (IgA) – a major effector response against commensal microbes. Mice lacking secretory antibodies, including IgA, exhibited a partial reversion of stroke-induced changes in microbiota composition. Together these findings demonstrate stroke is associated with dysregulation of antibody producing immune responses, which may in part explain changes in the intestinal microbiota. A mechanistic understanding of the immunological basis of stroke-associated pathologies in the periphery may open new avenues to manage the secondary complications and long-term prognosis of patients suffering from neurological disease.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"131 ","pages":"Article 106184"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145562797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of depression in adolescence signals improved inflammatory health in adulthood: results from a nationally representative longitudinal study 青春期抑郁症的诊断标志着成年期炎症健康的改善:一项具有全国代表性的纵向研究的结果。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-19 DOI: 10.1016/j.bbi.2025.106190
Jay O’Shields , George M. Slavich , Orion Mowbray

Objective

Childhood maltreatment increases subsequent risk for major depressive disorder (MDD), potentially through inflammatory pathways. The timely diagnosis and treatment of MDD may thus interrupt the association between inflammation and depressive symptoms, but diagnosis is frequently delayed. Additionally, sex-differences may affect timely diagnosis and treatment, contributing to differences in inflammation and depressive symptoms as individuals age.

Method

We used data from the nationally representative National Longitudinal Study of Adolescent to Adult Health to examine how diagnosis of MDD in adolescence vs. adulthood affected associations between childhood maltreatment, C-reactive protein (CRP) levels, and depressive symptoms in adulthood. We used path analysis to examine associations between these variables and then tested for sex differences by moderating pathways by sex.

Results

Childhood maltreatment increased the risk of being diagnosed with MDD at any time, and being diagnosed with MDD was associated with greater depressive symptoms in adulthood. Diagnosis of MDD at any time was associated with greater depressive symptoms, but diagnosis of MDD in adolescence was associated with lower CRP levels relative to diagnosis in adulthood. Sex differences analysis indicated that CRP was greatest for males diagnosed in adulthood despite females being diagnosed in adulthood having a greater body mass index.

Conclusion

Diagnosing MDD in adolescence was associated with better inflammatory health in adulthood. Timelier diagnosing and treatment of MDD after symptom onset may improve overall prognosis, particularly for males, and reduce the risk for other inflammation-related conditions.
目的:儿童虐待可能通过炎症途径增加重度抑郁症(MDD)的风险。因此,及时诊断和治疗重度抑郁症可能会中断炎症和抑郁症状之间的联系,但诊断经常被延迟。此外,性别差异可能会影响及时的诊断和治疗,导致个体随着年龄的增长炎症和抑郁症状的差异。方法:我们使用了具有全国代表性的青少年到成人健康国家纵向研究的数据,以检查青春期和成年期MDD的诊断如何影响儿童虐待、c反应蛋白(CRP)水平和成年期抑郁症状之间的关联。我们使用通径分析来检查这些变量之间的关联,然后通过性别调节途径来测试性别差异。结果:儿童时期的虐待增加了在任何时候被诊断为重度抑郁症的风险,并且被诊断为重度抑郁症与成年后更大的抑郁症状相关。在任何时候诊断MDD都与更严重的抑郁症状相关,但青春期诊断MDD与成年诊断相比,CRP水平较低。性别差异分析表明,成年后确诊的男性CRP最高,尽管成年后确诊的女性体重指数更高。结论:青春期诊断MDD与成年期炎症健康状况良好相关。在症状出现后及时诊断和治疗重度抑郁症可能改善总体预后,特别是对男性,并降低其他炎症相关疾病的风险。
{"title":"Diagnosis of depression in adolescence signals improved inflammatory health in adulthood: results from a nationally representative longitudinal study","authors":"Jay O’Shields ,&nbsp;George M. Slavich ,&nbsp;Orion Mowbray","doi":"10.1016/j.bbi.2025.106190","DOIUrl":"10.1016/j.bbi.2025.106190","url":null,"abstract":"<div><h3>Objective</h3><div>Childhood maltreatment increases subsequent risk for major depressive disorder (MDD), potentially through inflammatory pathways. The timely diagnosis and treatment of MDD may thus interrupt the association between inflammation and depressive symptoms, but diagnosis is frequently delayed. Additionally, sex-differences may affect timely diagnosis and treatment, contributing to differences in inflammation and depressive symptoms as individuals age.</div></div><div><h3>Method</h3><div>We used data from the nationally representative National Longitudinal Study of Adolescent to Adult Health to examine how diagnosis of MDD in adolescence vs. adulthood affected associations between childhood maltreatment, C-reactive protein (CRP) levels, and depressive symptoms in adulthood. We used path analysis to examine associations between these variables and then tested for sex differences by moderating pathways by sex.</div></div><div><h3>Results</h3><div>Childhood maltreatment increased the risk of being diagnosed with MDD at any time, and being diagnosed with MDD was associated with greater depressive symptoms in adulthood. Diagnosis of MDD at any time was associated with greater depressive symptoms, but diagnosis of MDD in adolescence was associated with lower CRP levels relative to diagnosis in adulthood. Sex differences analysis indicated that CRP was greatest for males diagnosed in adulthood despite females being diagnosed in adulthood having a greater body mass index.</div></div><div><h3>Conclusion</h3><div>Diagnosing MDD in adolescence was associated with better inflammatory health in adulthood. Timelier diagnosing and treatment of MDD after symptom onset may improve overall prognosis, particularly for males, and reduce the risk for other inflammation-related conditions.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"132 ","pages":"Article 106190"},"PeriodicalIF":7.6,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145573076","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early microglia-mediated neuroinflammation after status epilepticus causes behavioral dysfunction and neurocognitive deficits but not epilepsy in mice 癫痫持续状态后早期小胶质细胞介导的神经炎症导致小鼠行为功能障碍和神经认知缺陷,但不会导致癫痫。
IF 7.6 2区 医学 Q1 IMMUNOLOGY Pub Date : 2025-11-13 DOI: 10.1016/j.bbi.2025.106183
Peravina Thergarajan , Gadeer Al-Hobaish , Grace Sutherland , Evelyn Tsantikos , Bianca Jupp , Mohammad B. Haskali , Pablo M. Casillas-Espinosa , Margaret L. Hibbs , Terence J. O’Brien , Idrish Ali , Nigel C. Jones

Background

Neuroinflammation is implicated in epilepsy pathogenesis, and microglia are key immune cells of the brain that participate in neuroinflammatory responses associated with epilepsy. This study investigated the role of early microglial activation following an epileptogenic brain injury on the incidence and severity of epilepsy and associated neurobehavioral impairments in a model of acquired epilepsy.

Methods

Status epilepticus (SE) was induced in male C57BL/6 mice via electrical stimulation of the ventral hippocampus, while additional mice were enrolled as sham controls (n = 125 total). Following termination of SE, mice received injections of the colony stimulating factor 1 (CSF1) receptor inhibitor PLX5622 (PLX; 50 mg/kg ip twice daily) to suppress microglial activation caused by SE, or vehicle, for seven days. At the end of treatment, the effect of microglial suppression on the neuroinflammatory response to SE was characterised using gene expression, immunohistochemistry, and flow cytometry. Additional mice were followed for four months and underwent a series of neurobehavioral tests and epilepsy assessment.

Results

PLX treatment significantly reduced Iba1 + cell counts, reduced GFAP + immunoreactivity, and downregulated the expression of proinflammatory cytokines in the hippocampus compared to vehicle following SE, intimating that the neuroinflammatory response of SE was suppressed by PLX. Flow cytometry revealed that SE significantly reduced microglial expression of CX3CR1 and CD206, but increased expression of CD16/32, shifting microglia towards a pro-inflammatory state. However, PLX treatment did not influence the relative expression of these genes. In the chronic stage, SE mice treated with PLX exhibited improved spatial memory (Y-maze test: p = 0.0016) and reduced depressive-like behavior (tail suspension test: p = 0.04; sucrose preference: p = 0.14) compared to vehicle-treated SE mice. However, PLX treatment did not alter the incidence of epilepsy after SE (58 % in vehicle treated mice vs 50 % PLX treated mice; p = 0.65) or seizure frequency in epileptic animals.

Conclusion

Suppression of microgliosis with PLX eliminates the neuroinflammatory response after SE, and this is associated with prevention of long-term behavioral impairment. However, this intervention does not influence the development of epilepsy. These results demonstrate that acquired epilepsy and its behavioral comorbidities have different pathogenic mechanisms after SE, with early microglial driven neuroinflammation most relevant to the latter.
背景:神经炎症与癫痫发病有关,小胶质细胞是大脑中参与癫痫相关神经炎症反应的关键免疫细胞。本研究探讨了在获得性癫痫模型中,癫痫性脑损伤后早期小胶质细胞激活在癫痫发生率和严重程度以及相关神经行为障碍中的作用。方法:通过电刺激雄性C57BL/6小鼠腹侧海马诱导癫痫持续状态(SE),另设假对照组(n = 共125只)。SE终止后,小鼠注射集落刺激因子1 (CSF1)受体抑制剂PLX5622 (PLX; 50 mg/kg ip,每日两次),以抑制SE或载药引起的小胶质细胞活化,持续7天。在治疗结束时,使用基因表达、免疫组织化学和流式细胞术表征小胶质细胞抑制对SE神经炎症反应的影响。另外的老鼠被跟踪了四个月,接受了一系列的神经行为测试和癫痫评估。结果:与SE后对照相比,PLX治疗显著降低了Iba1 + 细胞计数,降低了GFAP + 免疫反应性,下调了海马中促炎细胞因子的表达,提示PLX抑制了SE的神经炎症反应。流式细胞术显示,SE显著降低了小胶质细胞CX3CR1和CD206的表达,但增加了CD16/32的表达,使小胶质细胞转向促炎状态。然而,PLX处理不影响这些基因的相对表达。在慢性期,经PLX处理的SE小鼠空间记忆能力(y迷宫试验:p = 0.0016)和抑郁样行为(悬尾试验:p = 0.04;蔗糖偏好:p = 0.14)均明显优于载药处理的SE小鼠。然而,PLX治疗并没有改变SE后癫痫的发生率(小鼠58 % vs小鼠50 % PLX治疗;p = 0.65)或癫痫动物的发作频率。结论:PLX抑制小胶质细胞增生可消除SE后的神经炎症反应,这与预防长期行为损害有关。然而,这种干预并不影响癫痫的发展。这些结果表明,SE后获得性癫痫及其行为合并症具有不同的致病机制,其中早期小胶质细胞驱动的神经炎症与后者最为相关。
{"title":"Early microglia-mediated neuroinflammation after status epilepticus causes behavioral dysfunction and neurocognitive deficits but not epilepsy in mice","authors":"Peravina Thergarajan ,&nbsp;Gadeer Al-Hobaish ,&nbsp;Grace Sutherland ,&nbsp;Evelyn Tsantikos ,&nbsp;Bianca Jupp ,&nbsp;Mohammad B. Haskali ,&nbsp;Pablo M. Casillas-Espinosa ,&nbsp;Margaret L. Hibbs ,&nbsp;Terence J. O’Brien ,&nbsp;Idrish Ali ,&nbsp;Nigel C. Jones","doi":"10.1016/j.bbi.2025.106183","DOIUrl":"10.1016/j.bbi.2025.106183","url":null,"abstract":"<div><h3>Background</h3><div>Neuroinflammation is implicated in epilepsy pathogenesis, and microglia are key immune cells of the brain that participate in neuroinflammatory responses associated with epilepsy. This study investigated the role of early microglial activation following an epileptogenic brain injury on the incidence and severity of epilepsy and associated neurobehavioral impairments in a model of acquired epilepsy.</div></div><div><h3>Methods</h3><div>Status epilepticus (SE) was induced in male C57BL/6 mice via electrical stimulation of the ventral hippocampus, while additional mice were enrolled as sham controls (n = 125 total). Following termination of SE, mice received injections of the colony stimulating factor 1 (CSF1) receptor inhibitor PLX5622 (PLX; 50 mg/kg ip twice daily) to suppress microglial activation caused by SE, or vehicle, for seven days. At the end of treatment, the effect of microglial suppression on the neuroinflammatory response to SE was characterised using gene expression, immunohistochemistry, and flow cytometry. Additional mice were followed for four months and underwent a series of neurobehavioral tests and epilepsy assessment.</div></div><div><h3>Results</h3><div>PLX treatment significantly reduced Iba1 + cell counts, reduced GFAP + immunoreactivity, and downregulated the expression of proinflammatory cytokines in the hippocampus compared to vehicle following SE, intimating that the neuroinflammatory response of SE was suppressed by PLX. Flow cytometry revealed that SE significantly reduced microglial expression of CX3CR1 and CD206, but increased expression of CD16/32, shifting microglia towards a pro-inflammatory state. However, PLX treatment did not influence the relative expression of these genes. In the chronic stage, SE mice treated with PLX exhibited improved spatial memory (Y-maze test: p = 0.0016) and reduced depressive-like behavior (tail suspension test: p = 0.04; sucrose preference: p = 0.14) compared to vehicle-treated SE mice. However, PLX treatment did not alter the incidence of epilepsy after SE (58 % in vehicle treated mice vs 50 % PLX treated mice; p = 0.65) or seizure frequency in epileptic animals.</div></div><div><h3>Conclusion</h3><div>Suppression of microgliosis with PLX eliminates the neuroinflammatory response after SE, and this is associated with prevention of long-term behavioral impairment. However, this intervention does not influence the development of epilepsy. These results demonstrate that acquired epilepsy and its behavioral comorbidities have different pathogenic mechanisms after SE, with early microglial driven neuroinflammation most relevant to the latter.</div></div>","PeriodicalId":9199,"journal":{"name":"Brain, Behavior, and Immunity","volume":"131 ","pages":"Article 106183"},"PeriodicalIF":7.6,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145530623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Brain, Behavior, and Immunity
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1